UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of July 2021
Commission File Number: 001-39633
Abcam plc
(Translation of registrant’s name into English)
Discovery Drive
Cambridge Biomedical Campus
Cambridge, CB2 0AX
United Kingdom
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K
On July 01, 2021, Abcam plc (the “Company”) issued a regulatory news service announcement (the “Announcement”) announcing the results of its General Meeting held on July 01, 2020. The Announcement is furnished herewith as Exhibit 99.1 to this Report on Form 6-K.
EXHIBIT INDEX
Exhibit | Description | |
99.1 | Regulatory News Service Announcement dated July 01, 2021 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
ABCAM PLC
| ||||
Date: July 1, 2021 | By: | /s/ Alan Hirzel
| ||
Name: Alan Hirzel | ||||
Title: Chief Executive Officer |